LXEO (Lexeo Therapeutics) Float Percentage Of Total Shares Outstanding: 85.07% (As of Jul. 01, 2026)


LXEO Lexeo Therapeutics Inc LXEO
10 GF Score
Price $4.45
! 3 Warning Signs
View Full Analysis

What is Lexeo Therapeutics Float Percentage Of Total Shares Outstanding?

Lexeo Therapeutics LXEO -4.40% 10 Float Percentage Of Total Shares Outstanding is 85.07% as of Jul. 01, 2026. GuruFocus rates LXEO with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lexeo Therapeutics's float shares is 66.80 Mil. Lexeo Therapeutics's total shares outstanding is 78.52 Mil. Lexeo Therapeutics's float percentage of total shares outstanding is 85.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lexeo Therapeutics's Insider Ownership is 1.15%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lexeo Therapeutics's Institutional Ownership is 106.70%.

LXEO
10GF Score
Lexeo Therapeutics Inc LXEO
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lexeo Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Lexeo Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=66.80/78.52
=85.07%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 85.07% mean?
Lexeo Therapeutics (LXEO) has a Float Percentage Of Total Shares Outstanding of 85.07% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Lexeo Therapeutics and its competitors.
Is Lexeo Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Lexeo Therapeutics' current Float Percentage Of Total Shares Outstanding is 85.07%. Overall, Lexeo Therapeutics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Lexeo Therapeutics' Float Percentage Of Total Shares Outstanding compare to PROK and CMPX?
Lexeo Therapeutics' Float Percentage Of Total Shares Outstanding of 85.07% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Lexeo Therapeutics and its competitors. Lexeo Therapeutics's current Float Percentage Of Total Shares Outstanding is 85.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lexeo Therapeutics stock overvalued right now?
Lexeo Therapeutics (LXEO) has a current Float Percentage Of Total Shares Outstanding of 85.07%. The current Float Percentage Of Total Shares Outstanding is 85.07%. Lexeo Therapeutics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Lexeo Therapeutics (LXEO), the current Float Percentage Of Total Shares Outstanding is 85.07% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lexeo Therapeutics Business Description

Address 345 Park Avenue South, Floor 6, New York, NY, USA, 10010
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
10GF Score

Get the complete analysis for LXEO

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.45
Price